Physician profile
Roberto Santamaria
NPI 1003481052
$3,145.64
in general payments reported to CMS, 2019-2025
14 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.69 · 2022: $75.51 · 2023: $745 · 2024: $2,136 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,983 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,982.60 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $714.61 | 2023-2024 | Invega Sustenna, Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $513.30 | 2022-2024 | Caplyta |
| Vanda Pharmaceuticals INC. | $359.88 | 2023-2024 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $282.00 | 2021-2024 | Ingrezza |
| Abbvie INC. | $268.37 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $258.95 | 2023-2025 | Uzedy, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $197.78 | 2023-2024 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Axsome Therapeutics, INC. | $155.44 | 2024-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $115.04 | 2024 | Cobenfy |
| Alkermes, INC. | $104.27 | 2023-2024 | Aristada, Lybalvi |
| Indivior INC. | $93.79 | 2024 | Perseris |
| Almatica Pharma LLC | $38.86 | 2023 | Loreev Xr |
| Lundbeck LLC | $22.96 | 2022 | |
| Idorsia Pharmaceuticals US INC | $20.39 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Santamaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.